KXA
LUNG icon

KPCB XIII Associates’s Pulmonx LUNG Stock Holding History

KPCB XIII Associates’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$10.3M Hold
994,971
– – 5.53% 2
2023
Q2 		$13M Hold
994,971
– – 5.83% 2
2023
Q1 		$11.1M Hold
994,971
– – 4.92% 2
2022
Q4 		$8.39M Buy
+994,971
New +$9.46M 3.99% 2
2021
Q3 		$35.8M Hold
994,971
– – 7.14% 2
2021
Q2 		$43.9M Hold
994,971
– – 8.08% 2
2021
Q1 		$45.5M Sell
994,971
-426,415
-30% -$24.5M 9.35% 2
2020
Q4 		$88.3M Buy
+1,421,386
New +$69.6M 14.27% 2

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

KPCB XIII Associates's LUNG Position: Q3 2023 in Review

KPCB XIII Associates held its Pulmonx (LUNG) position steady in Q3 2023 at 994,971 shares worth $10.3M. The position accounts for 5.53% of the portfolio, ranked #2.

KPCB XIII Associates first reported a position in LUNG in Q4 2020 and has held it in 8 quarters since. The position peaked at $88.3M in Q4 2020. 117 funds tracked by Wall St. Rank hold LUNG as of Q3 2023.

  • KPCB XIII Associates held 994,971 shares of Pulmonx worth $10.3M as of Q3 2023.
  • KPCB XIII Associates left its Pulmonx share count unchanged in Q3 2023.
  • Pulmonx made up 5.53% of KPCB XIII Associates's portfolio in Q3 2023, its #2 holding.
  • KPCB XIII Associates first reported a position in Pulmonx in Q4 2020 and has held it in 8 quarters since.
  • KPCB XIII Associates's Pulmonx position peaked at $88.3M in Q4 2020.
  • 117 funds tracked by Wall St. Rank held Pulmonx as of Q3 2023.

Based on KPCB XIII Associates's 13F filing for Q3 2023, filed 8 Nov 2023.